A Close Look at the Endothelium: Its Role in the Regulation of Vasomotor Tone

European Urology, Supplements

Volumn 8, Issue 2, 2009, Pages 48-57

  Mas, Manuel ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Angiotensin II; EDHF; Endothelin 1; Endothelium; eNOS uncoupling; Nitric oxide; Prostanoids; Reactive oxygen species; Shear stress

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2;

ADRENERGIC SYSTEM; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; MEDLINE; MUSCLE TONE; PRIORITY JOURNAL; REVIEW; SCIENTIFIC LITERATURE; SMOOTH MUSCLE CONTRACTILITY; VASOMOTOR REFLEX;

EID: 57049108661     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2008.10.011     Document Type: Review

References (44)

1. Laubichler M.D., Aird W.C., and Maienschein J. The endothelium in history. In: Aird W.C. (Ed). Endothelial Biomedicine (2007), Cambridge University Press, New York, NY 5-19
2. Wolinsky H. A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res 42 (1980) 301-311
3. Pries A.R., Secomb T.W., and Gaehtgens P. The endothelial surface layer. Pflügers Arch 440 (2000) 653-666
4. Cajal S.R. Algunas variaciones fisiológicas y patológicas del aparato reticular de Golgi. Trab Lab Invest Biol Univ Madrid 12 (1914) 127-227
5. Weibel E.R., and Palade G.E. New cytoplasmic components in arterial endothelia. J Cell Biol 23 (1964) 101-112
6. Davidson S.M., and Duchen M.R. Endothelial mitochondria: contributing to vascular function and disease. Circ Res 100 (2007) 1128-1141
7. Quintero M., Colombo S.L., Godfrey A., and Moncada S. Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci U S A 103 (2006) 5379-5384
8. Lowenstein C.J., Morrell C.N., and Yamakuchi M. Weibel-Palade bodies. Vesicular trafficking on the vascular highway. In: Aird W.C. (Ed). Endothelial Biomedicine (2007), Cambridge University Press, New York, NY 657-663
9. Tarbell J.M., and Pahakis M.Y. Mechanotransduction and the glycocalyx. J Intern Med 259 (2006) 339-350
10. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5 (2004) 261-270
11. Davis G.E., and Senger D.R. Endothelial extracellular matrix: biosynthesis, remodelling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97 (2005) 1093-1107
12. Rummery N.M., and Hill C.E. Vascular gap junctions and implications for hypertension. Clin Exp Pharmacol Physiol 31 (2004) 659-667
13. de Wit C., Hoepfl B., and Wölfle S.E. Endothelial mediators and communication through vascular gap junctions. Biol Chem 387 (2006) 3-9
14. Pries A.R., and Kuebler W.M. Normal endothelium. In: Moncada S., and Higgs A. (Eds). The Vascular Endothelium I (Handbook of Experimental Pharmacology 176/I) (2006), Springer, Berlin, Germany 1-40
15. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100 (2007) 158-173
16. Aird W.C. Spatial and temporal dynamics of the endothelium. J Thromb Haemostasis 3 (2005) 1392-1406
17. Mombouli J.-V., and Vanhoutte P.M. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 31 (1999) 61-74
18. Li H., Wallerath T., and Förstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7 (2002) 132-147
19. Rojas-Rubio A., and Morales-Segura M.A. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res 35 (2004) 1-11
20. Marin R., Escrig A., Abreu P., and Mas M. Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive NOS isoenzymes. Biol Reprod 61 (1999) 1012-1018
21. Escrig A., Marin R., and Mas M. Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms. J Urol 162 (1999) 2205-2210
22. Busse R., and Fleming I. Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci 24 (2003) 24-29
23. Hambrecht R., Adams V., Erbs S., et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107 (2003) 3152-3158
24. Haynes M.P., Sinha D., Russell K.S., et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-Kinase-Akt pathway in human endothelial cells. Circ Res 87 (2000) 677-682
25. Muniyappa R., Montagnani M., Koh K.K., and Quon M.J. Cardiovascular actions of insulin. Endocr Rev 28 (2007) 463-491
26. Cai H., Li Z., Davis M.E., Kanner W., Harrison D.G., and Dudley Jr. S.C. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol 63 (2003) 325-331
27. Widder J.D., Chen W., Li L., Dikalov S., Thöny B., Hatakeyama K., et al. Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res 101 (2007) 830-838
28. Moens A.L., and Kass D.A. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. J Cardiovasc Pharmacol 50 (2007) 238-246
29. Escrig A., Marin R., Abreu P., Gonzalez-Mora J.L., and Mas M. Changes in mating behaviour, erectile function, and nitric oxide levels in penile corpora cavernosa in streptozotocin-diabetic rats. Biol Reprod 66 (2002) 185-189
30. Li H., Wallerath T., Münzel T., and Förstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7 (2002) 149-164
31. Schmidt T.S., and Alp N.J. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Colch) 113 (2007) 47-63
32. Förstermann U., and Münzel T. Endothelial nitric oxide synthase in vascular disease. From marvel to menace. Circulation 113 (2001) 1708-1714
33. Parkington H.C., Coleman H.A., and Tare M. Prostacyclin and endothelium-dependent hyperpolarization. Pharmacol Res 49 (2004) 509-514
34. Krötz F., Schiele T.M., Klauss V., and Sohn H.-Y. Selective COX-2 inhibitors and risk of myocardial infarction. J Vasc Res 42 (2005) 312-324
35. de Wit C., and Wölfle S.E. EDHF and gap junctions: important regulators of vascular tone within the microcirculation. Curr Pharm Biotechnol 8 (2007) 11-25
36. Griffith T.M. Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?. Br J Pharmacol 141 (2004) 881-903
37. Jackson G. Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. Am J Cardiol 96 Suppl (2005) 32M-36M
38. Pohl U., and de Wit C. A unique role of NO in the control of blood flow. News Physiol Sci 14 (1999) 74-80
39. Norel X. Prostanoid receptors in the human vascular wall. Sci World J 7 (2007) 1359-1374
40. Paravicini T.M., and Touyz R.M. Redox signaling in hypertension. Cardiovasc Res 71 (2006) 247-258
41. Lavallée M., Takamura M., Parent R., and Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6 (2001) 365-376
42. Cardillo C., Campia U., Kilcoyne C.M., Bryant M.B., and Panza J.A. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 105 (2002) 452-456
43. Tuyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz J Med Biol Res 37 (2004) 1263-1273
44. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res 98 (2006) 887-896